Postdoctoral scholar: Kidney microvasculature in Basel
Die Nocartis AG hat seinen Sitz in Basel und ist eines der grössten Pharmaunternehmen der Welt!
Postdoctoral scholar: Kidney microvasculature
Job Description The Novartis Institutes for BioMedical Research (NIBR) is the innovation engine of Novartis. We collaborate across scientific and organizational boundaries, with a focus on powerful new technologies that have the potential to help produce therapeutic breakthroughs for patients.
We are seeking a highly motivated postdoctoral fellow to join our nephrology research group. The project will focus on investigating the molecular mechanisms of endothelial cell functions in kidney, aiming to discover new therapeutic targets for chronic kidney disease, a major public health issue. A PhD in vascular biology with expertise in cell biology techniques is required. Knowledge of kidney biology and experience in bioengineering are considered a plus.
The successful candidate will join a vibrant scientific community and collaborate with other postdoctoral fellows mentored by a range of scientists across disciplines and platforms, including chemistry, structural biology, molecular biology, functional genomics, neurophysiology and translational medicine. Postdoctoral scholars at NIBR have a unique opportunity to conduct innovative, interdisciplinary research and are expected to publish their results in leading journals. The postdoctoral term is up to 4 years.
Minimum requirementsQualifications: • PhD degree in vascular biology (PhD students in the last year of their thesis work are eligible to apply) • Experience in nephrology research and in bioengineering will be considered a plus • Strong publication record • Excellent analytical, communication and organizational skills • Candidates must be able to work independently as well as with interdisciplinary teams #PDX
For more information about our postdoctoral program, please visit https://www.novartis.com/our-science/postdoc-program
Why consider Novartis? 750 million. That’s how many lives our products touch. And while we’re proud of that, in this world of digital and technological transformation, we must also ask ourselves this: how can we continue to improve and extend even more people’s lives?
We believe the answers are found when curious, courageous and collaborative people like you are empowered to ask new questions, make bolder decisions and take smarter risks.
We are Novartis. Join us and help reimagine medicine.